JD Health International Inc.

SEHK:6618 Stock Report

Market Cap: HK$84.8b

JD Health International Future Growth

Future criteria checks 3/6

JD Health International is forecast to grow earnings and revenue by 18.1% and 13.3% per annum respectively. EPS is expected to grow by 17.5% per annum. Return on equity is forecast to be 8% in 3 years.

Key information

18.1%

Earnings growth rate

17.5%

EPS growth rate

Consumer Retailing earnings growth28.0%
Revenue growth rate13.3%
Future return on equity8.0%
Analyst coverage

Good

Last updated24 Apr 2024

Recent future growth updates

Recent updates

JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

Apr 17
JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return

Apr 08
JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return

At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?

Mar 01
At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?

Revenues Tell The Story For JD Health International Inc. (HKG:6618)

Jan 16
Revenues Tell The Story For JD Health International Inc. (HKG:6618)

JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends

Dec 07
JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends

What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?

Nov 20
What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?

JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate

Nov 02
JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate

Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

Aug 21
Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price

Aug 03
JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price

JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues

Jun 08
JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues

Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?

Apr 19
Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?

Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

Dec 29
Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?

Sep 14
Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?

A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Dec 04
A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Mar 08
Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Earnings and Revenue Growth Forecasts

SEHK:6618 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202683,9294,1138,1618,54516
12/31/202572,7163,1846,2377,69717
12/31/202462,1112,4104,6565,81218
12/31/202353,5302,1424,6054,605N/A
9/30/202353,5761,9303,1654,311N/A
6/30/202353,6211,7181,7264,017N/A
3/31/202350,1791,0492,6794,961N/A
12/31/202246,7363803,6325,905N/A
9/30/202242,003-73,4404,829N/A
6/30/202237,270-3953,2493,753N/A
3/31/202233,976-7343,0853,592N/A
12/31/202130,682-1,0742,9213,431N/A
9/30/202127,463-6,7024,0684,352N/A
6/30/202124,243-12,3315,2165,274N/A
3/31/202121,813-14,7834,4394,487N/A
12/31/202019,383-17,2343,6623,699N/A
9/30/202017,007-11,9011,9802,004N/A
6/30/202014,631-6,567298309N/A
3/31/202012,737-3,769351359N/A
12/31/201910,842-972404409N/A
12/31/20188,169215185187N/A
12/31/20175,5531792836N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6618's forecast earnings growth (18.1% per year) is above the savings rate (2%).

Earnings vs Market: 6618's earnings (18.1% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

High Growth Earnings: 6618's earnings are forecast to grow, but not significantly.

Revenue vs Market: 6618's revenue (13.3% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).

High Growth Revenue: 6618's revenue (13.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6618's Return on Equity is forecast to be low in 3 years time (8%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.